Validation of a predictive model that identifies patients at high risk of developing febrile neutropaenia following chemotherapy for breast cancer.

@article{Jenkins2012ValidationOA,
  title={Validation of a predictive model that identifies patients at high risk of developing febrile neutropaenia following chemotherapy for breast cancer.},
  author={Peter Leon Jenkins and Jennifer Scaife and Sylvie Freeman},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2012},
  volume={23 7},
  pages={1766-71}
}
BACKGROUND We have previously developed a predictive model that identifies patients at increased risk of febrile neutropaenia (FN) following chemotherapy, based on pretreatment haematological indices. This study was designed to validate our earlier findings in a separate cohort of patients undergoing more myelosuppressive chemotherapy supported by growth factors. PATIENTS AND METHODS We conducted a retrospective analysis of 263 patients who had been treated with adjuvant docetaxel, adriamycin… CONTINUE READING
10 Citations
29 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the original articles

  • O Penack, D Buchheidt, al.. Christopeit M et
  • Annals of Oncology  | Jenkins et al. Volume
  • 2011
1 Excerpt

Risk factors for chemotherapyinduced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study

  • M Schwenkglenks, R Pettengell, al.. Jackisch C et
  • Support Care Cancer
  • 2011
2 Excerpts

Similar Papers

Loading similar papers…